Suspended PHASE3 INTERVENTIONAL 2-arm NCT00978224

Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment

Efficacy of Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment

Sponsor: Catalysis SL

Conditions Chronic Inflammatory Syndrome

Updated 5 times since 2017 Last updated: Jul 6, 2010 Started: Oct 31, 2009 Primary completion: Sep 30, 2011 Completion: Sep 30, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Decision of the investigator

Listed as NCT00978224, this PHASE3 trial focuses on Chronic Inflammatory Syndrome and remains suspended. Sponsored by Catalysis SL, it has been updated 5 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Suspended PHASE3
Jul 2024 — Sep 2024 [monthly]

Suspended PHASE3
Jan 2021 — Jul 2024 [monthly]

Suspended PHASE3
Jun 2018 — Jan 2021 [monthly]

Suspended PHASE3
Jan 2017 — Jun 2018 [monthly]

Suspended PHASE3

First recorded

Oct 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Catalysis SL

Data source: Catalysis SL

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Havana, Cuba